TrialJournal of psychopharmacology (Oxford, England)2022

Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study.

Michael Cronquist Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.